If the AD-related pathological process were indeed to be driven by the presence of Aβ, we would expect to find an abrupt appearance of abnormal tau in the temporal allocortex, i.e., a distribution of tau lesions corresponding to NFT stage III. This evidence concerns the gene MAPT and Alzheimer disease.